Connect with us

Eyecare

Eye Health Firm Acquired in $100M+ Deal

mm

Published

on

It’s working on a glaucoma treatment.

TOKYO and CAMBRIDGE, ENGLAND — Tokyo-based Astellas Pharma Inc. has acquired Quethera Ltd., a U.K.-based gene therapy company that is developing treatments for ocular disorders such as glaucoma.

Astellas may pay up to £85 million (about $109.8 million at today’s exchange rate) to Quethera shareholders, including upfront and contingent amounts. Founded in 2013, Quethera has now become a wholly owned subsidiary of Astellas.

“Quethera’s novel technology approach is focused on exploring potential treatment options for common ophthalmic diseases, such as glaucoma, that can cause blindness and severely affect the quality of life for patients,” said Peter Widdowson, CEO of Quethera. “This deal enables us to accelerate our evaluation of this investigational technology program to see if we can slow or prevent disease progression for these patients.”

The acquisition includes Quethera’s ophthalmic gene therapy program. It “uses a recombinant adeno-associated viral vector system (rAAV) to introduce therapeutic genes into target retinal cells for the treatment of glaucoma,” according to a press release.

Advertisement

Success with the program “would address a high unmet medical need in glaucoma patients who are at risk of losing their eyesight,” said Kenji Yasukawa, president and CEO of Astellas.

SPONSORED VIDEO

Meet the Next Generation of Smart Glasses

Ray-Ban Meta is now available with a full range of lenses, as a complete pair or edged lens. Prescription orders eligible through select insurance providers, including Eyemed and private pay. The Ray-Ban Meta collection combines iconic design with cutting-edge technology. Capture life’s best moments and livestream to Facebook and Instagram with an upgraded 12 MP camera and five-mic system. Stay connected with hands-free calls and messages. Listen to your favorite tracks through built-in speakers. Spark your creativity, get information and control your glasses with your voice – powered by Meta AI. All while keeping your phone in your pocket. For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular